Los Angeles, CA42 Active Studies

Ulcerative Colitis Clinical Trials in Los Angeles, CA

Find 42 actively recruiting ulcerative colitis clinical trials in Los Angeles, CA. Connect with local research sites and explore new treatment options.

42
Active Trials
34
Sponsors
22,453
Enrolling

Recruiting Ulcerative Colitis Studies in Los Angeles

About Ulcerative Colitis Clinical Trials in Los Angeles

Ulcerative colitis is a chronic inflammatory bowel disease that causes inflammation and ulcers in the innermost lining of the colon and rectum. It typically presents with bloody diarrhea, abdominal pain, and urgency. Treatment includes aminosalicylates, corticosteroids, immunosuppressants, and biologics.

There are currently 42 ulcerative colitis clinical trials recruiting participants in Los Angeles, CA. These studies are seeking a combined 22,453 participants. Research is being sponsored by Genzyme, a Sanofi Company, Bristol-Myers Squibb, Sanofi and 31 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ulcerative Colitis Clinical Trials in Los Angeles — FAQ

Are there ulcerative colitis clinical trials in Los Angeles?

Yes, there are 42 ulcerative colitis clinical trials currently recruiting in Los Angeles, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Los Angeles?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Los Angeles research site will contact you about next steps.

Are clinical trials in Los Angeles free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Los Angeles studies also compensate for your time and travel.

What ulcerative colitis treatments are being tested?

The 42 active trials in Los Angeles are testing new therapies including novel drugs, biologics, and treatment approaches for ulcerative colitis.

Data updated July 17, 2026 from ClinicalTrials.gov